Rajko Kusec

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 2

Top Topics

Diffuse Large B Cell Lymphoma

Placebo Controlled

Epstein Barr Virus

Top Venues

Therapeutics and clinical risk management

Wiener klinische Wochenschrift

This page only lists publications with an associated author ORCID identifier.

Publications

Marko Lucijanic, Renata Huzjan Korunic, Martina Sedinic, Rajko Kusec, Vlatko Pejsa
More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features. Therapeutics and clinical risk management 17 (2021)
Davor Galusic, Marko Lucijanic, Ana Livun, Maja Radman, Jelena Lucijanic, Irena Drmic Hofman, Rajko Kusec
CDC25c expression in patients with myelofibrosis is associated with stronger myeloproliferation and shorter overall survival. Wiener klinische Wochenschrift (2020)